Cancer Horizons7 Jan 2021

S3 Ep59: Sharing Encouragement After a Cancer Diagnosis

Despite having different lung cancer journeys, two patients and a caregiver found similar hope in support. Ron Simmons is a two-time cancer survivor who was first diagnosed with stage 1 colorectal cancer in 2013. When routine bloodwork led him to visit a pulmonologist in January of 2017, he was diagnosed with what was thought to be a collapsed lung. The following December, Ron fell ill and further chest scans led to his stage 3 non-small cell lung cancer diagnosis. Through his experience, he is a firm believer in getting a second opinion. Heidi Nafman-Onda is a health educator and fitness trainer who always led a healthy lifestyle. Because of symptoms for an ovarian cyst, her physician ordered her to undergo a CT scan of her chest, abdomen and pelvis to rule out anything worrisome. It was then that they found a mass in her upper left lobe of her lung as well as malignant lymph nodes in the middle of her chest. Despite having no symptoms for lung cancer, Heidi was diagnosed with stage 3a adenocarcinoma and her pulmonologist told her to get her affairs in order. She and her husband, Pierre, were in complete shock, as Heidi said she started to feel hopeless. Shortly thereafter, Heidi also underwent further scans to see if she had any metastases. Her scans showed no signs that the disease had spread and, in turn, she began to feel the pendulum of emotions swing toward hope. In this week’s episode, we spoke with Ron, Heidi and Pierre about their experiences, feelings of hope and the value of a second opinion.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(295)

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berg...

31 Dec 202514min

S7 Ep1: The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

18 Mars 202510min

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

17 Sep 202419min

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another ca...

4 Mars 20247min

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, an...

4 Mars 202410min

S6 Ep20: FDA Approvals from February 2024

Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. ...

23 Feb 20246min

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

Last week, we saw some FDA approvals for a new drug regimens, as well as some expert opinion about cancer vaccines. Additionally research touched upon the potential benefit of concurrent ctDNA and tum...

19 Feb 20249min

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews. Also last week, we covered researc...

12 Feb 20247min